Additionally, it is worth noting that, as an independent risk factor for rapid disease progression of CLL patients, decreased TCF1 and BCL11B expression coincided with high-risk indicators for CLL, including unmutated IGHV and TP53 aberration. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.